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Abstract
Sulfotransferases are enzymes that catalyze the transfer of sulfo groups from a donor, for example
3′-phosphoadenosine 5′-phosphosulfate, to an acceptor, for example the amino or hydroxyl
groups of a small molecule, xenobiotic, carbohydrate, or peptide. These enzymes are important
targets in the design of novel therapeutics for treatment of a variety of diseases. This review
examines assays used for this important class of enzyme, paying particular attention to
sulfotransferases acting on carbohydrates and peptides and the major challenges associated with
their analysis.
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Sulfotransferase (ST) enzymes are responsible for catalyzing the transfer of a sulfo group
from a donor molecule, usually 3′-phosphoadenosine 5′-phosphosulfate (PAPS), to an
acceptor, for example a sugar, alcohol, phenol, or amine (Scheme 1). STs can be either
cytosolic or membrane-associated (Fig. 1). Cytosolic STs are key phase II metabolizing
enzymes involved in the clearance of small endogenous and exogenous compounds, for
example hormones, bioamines, drugs, and a variety of xenobiotic agents. Most of our
understanding of STs comes from the study of these cytosolic enzymes [1–4]. Membrane-
associated STs sulfonate larger biomolecules, for example carbohydrates and proteins, and
have recently been implicated in many critical biological processes [5]. Structure-based
sequence alignments have indicated that the structural fold and the PAPS-binding site are
conserved between cytosolic and Golgi STs. In both classes of enzyme, reactions involving
the transfer of sulfo groups are believed to proceed by in-line attack of the nucleophile at the
sulfate group of PAPS [3, 6].
Sulfo group transfer is an important reaction in the chemical metabolism of drugs, chemical
carcinogens, hormones, bile acids, neurotransmitters, peptides, and lipids [7]. Although STs
are emerging therapeutic drug targets and may be susceptible to enzyme-specific small
molecule inhibitors, this aspect of drug design is currently under-exploited. As the action
and mechanisms of these enzymes become better understood and high-throughput screening
assays are developed, discovery of ST inhibitors might also afford novel drugs for treatment
of cancer, inflammation, and infection, to improve and complement current therapy [8].
Robust enzyme activity assays are crucial to accelerate the progress of new drug
development related to STs, because they can provide optimum reaction control at minimum
cost of reagents and time. Enzyme assays quantify enzyme performance by monitoring
observable signals during conversion of substrate to product. Activity is expressed in terms
of “units”, usually defined as the formation of one μmole of product per minute at a
specified pH and temperature [9]. A variety of assay methods may be useful for determining
the activity of a particular enzyme. Each assay measures reaction velocity and should be
reliable, free from false positives or negatives, and easy to perform. Selection of an assay
method usually depends on convenience, availability of reagents and apparatus, and assay
sensitivity and throughput. Unique challenges in the design and development of ST assays
include enzyme type (i.e., cytosolic, Golgi, native, recombinant truncated—catalytic
domain, recombinant fusion protein—catalytic domain fused with another protein), purity,
stability, and substrate availability.
A brief review of ST assays, published over 20 years ago, highlighted an ion-pairing (IP)
extraction method for assay of aryl-STs [10]. This method relies on methylene blue and 2-
naphthol as substrates, thin-layer chromatography (TLC) for product separation, and
radioisotopic detection. Over the past two decades, in-vitro ST assays largely continue to
rely on incorporation of radioactive sulfur in PAP35S to determine ST substrate specificity
and ST activity. This review briefly describes these and other more recently developed
methods that are useful in determining ST activity to enable the better understanding of ST
catalysis needed to elucidate substrate-binding mechanisms and for the pharmacological
design of potent and specific ST inhibitors that are useful as new drugs.
Radiometric activity assays
Cytosolic ST enzyme activity and substrate specificity have mostly been determined by
quantification of the transfer of a PAP35S sulfo group to different substrates followed by
separation of the 35S-labeled products by use of gel-filtration chromatography [11, 12],
affinity chromatography [13–15], immobilization techniques [16], membranes [17], or high
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performance liquid chromatography (HPLC) [18, 19]. These procedures can be tedious for
routine and detailed kinetic studies of ST enzymes. However, the high sensitivity and speed
of these assays cause them to be widely used. Rates of reactions are non-continuously
determined by periodically removing samples from the reaction mixture. Radioactivity of
either product or residual substrate is then measured by liquid scintillation counting [20].
Such discontinuous methods are tedious and their accuracy can vary substantially,
potentially compromising the quality of the kinetic data reported. Thus, most literature
studies using a radioassay have not reported kinetic data. Despite these limitations,
radiometric assays are still widely adopted for determining enzyme activity because of their
universality—the radiolabel is incorporated in the PAP35S substrate common to all STs.
The activities of a variety of Golgi-derived STs have also been assayed radiometrically.
These enzymes pose a greater challenge because, unlike cytosolic enzymes, which act on
hydrophobic substrates that can be readily separated, with the product, from PAP35S, Golgi-
derived STs catalyze the conversion of hydrophilic substrates to an even more hydrophilic
product, confounding their separation from PAP35S.
Chondroitin 6-ST (C6ST) and chondroitin 4-ST (C4ST) activity have been determined by
using PAP35S with glycosaminoglycan substrates—chondroitin, chondroitin sulfate, and
dermatan sulfate. Enzyme conversion was followed by ethanol precipitation, sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), or membrane filtration to
separate the sulfated reaction products, and subsequent disaccharide analysis using HPLC
and scintillation counting to determine the amount of radioactivity incorporated into the
polysaccharide [21]. The activity of heparan sulfate 2-O-ST (2-O-ST), which transfers a
sulfo group to the 2-O-position of glucuronic or iduronic acid, has also been determined by
measuring the incorporation of 35S sulfo groups into N-sulfoheparosan or completely de-
sulfonated N-sulfonated heparin (CDSNS) [22] (Scheme 2). The 2-O-35S sulfo
polysaccharide was purified by diethylaminoethyl (DEAE) chromatography and assessed by
scintillation counting. The position of the sulfo group in the polysaccharide was determined
by disaccharide analysis using reversed-phase ion-pairing (RPIP) HPLC.
The activity of tyrosylprotein ST (TPST), which catalyzes the transfer of sulfo group from
PAPS to the phenolic oxygen of tyrosine residues within highly acidic groups of proteins
and polypeptides, was determined by measuring the transfer of 35S sulfo groups to an
immobilized peptide substrate by use of liquid scintillation counting [16]. A medium-
throughput radiolabel transfer-based assay for the well-characterized N-acetyl glucosamine
(GlcNAc)-6-ST NodH from Rhizobium meliloti involved separation of the product from the
excess PAP35S substrate, by use of silica gel thin-layer chromatography, and quantification
by phosphorimaging. In addition to the activity, the Michaelis–Menten constant (Km) was
reported for PAPS, as well as inhibition constants (Ki). This study led to the discovery of the
first reported carbohydrate ST inhibitors from a kinase-directed library [23].
Other substrate–product separation methods have been used in radiometric ST assays. These
methods have found application with substrates ranging from small molecules being acted
on by cytosolic STs, for example α-naphthol, to large molecules being acted on by Golgi
STs, for example proteoglycans, in which sulfated products and donor substrate PAP35S are
separated by electrophoresis using SDS-PAGE. Electrophoresis-based separations have been
demonstrated with both carbohydrate STs and TPSTs [24]. Dot-blotting radiometric activity
assays have been used in high-throughput screening, demonstrating the activity of two
carbohydrate STs, heparan sulfate N-deacetylase/N-ST and high-endothelial cell (HEC)
GlcNAc-6-O-ST on PAP35S and de-N-sulfonated heparin and N-acetylglucosamine,
respectively [17] (Scheme 3). The radiolabeled products were captured on a membrane and
then eluted, ready to be quantified, thus avoiding the need for a complicated purification
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step or repeated washing that is usually required in sample preparation for scintillation
counting. Although Km for PAPS and Ki values were reported, Km could not be determined
for the polymeric carbohydrate substrates, because of their heterogeneous nature and the
presence of multiple sulfation sites on each polymer chain. This method is useful for
inhibitor screening and should be useful for high-throughput microplate assays of other
carbohydrate STs.
Although radiometric ST assays are so prevalent, they remain expensive with PAP35S
costing ~$1,000/100 μCi, and 35S has a half-life of only 87.1 days. Disposal of spent
radioisotopes and regulatory compliance are also added costs associated with these assays.
Photometric activity assays
Photometric activity assays can be used for continuous rapid kinetic determinations for high-
throughput screening of potential substrates and inhibitors. Enzyme kinetic data, for
example Km and Vmax are often easily determined by spectrophotometric methods by taking
advantage of reactants that afford a new chromophore or undergo a detectable shift in
absorption at a characteristic wavelength during a reaction. Most of the assays reported
monitor the production of p-nitrophenol (PNP) [25–29], a few assays measure 2-naphthol
sulfation rates [30], and one assay describes the photometric measurement of cysteine
formed from sulfite [31].
One novel ST-coupled assay system involves the well-studied enzyme, aryl sulfotransferase
IV (AST-IV), which transfers a sulfo group from PAPS to aryl alcohols [27]. In this assay,
PAPS is continuously regenerated in ST-catalyzed reactions by using p-nitrophenyl sulfate
(PNPS) as a sulfo group donor, facilitating colorimetric monitoring of the PNP product at
400 nm (Scheme 4). The linear double-reciprocal plot generated gave apparent Km and Vmax
of several carbohydrate substrates and PAP in the reverse-physiological reaction similar to
published values from the physiological reaction. This assay could potentially be applied to
rapid kinetic determinations for carbohydrate and protein STs, enabling high-throughput
screening for potential ST substrates and inhibitors. Such an assay might be useful in the
biomedical screening of blood samples and other tissues for specific ST activity or the
concentration of ST substrates.
Another photometric method, called electrophoresis-mediated microanalysis (EMMA),
based on capillary electrophoresis with ultraviolet detection, has been used to assay the
activity of a phenol ST (SULT1A1) with PNP as a substrate. This assay uses initial rate
kinetics to afford a Km for PNP that is consistent with previously reported values [28].
EMMA uses electrophoresis to separate the inhibitor PAP from PAPS before injection of
enzyme and substrate inside the capillary. Photometric assays such as these are convenient,
fast, and simple, only requiring a substrate that is cleaved into a colorimetric co-product.
This assay is limited by small path lengths and requires concentrations above the nanomolar
range. However, compared with other spectrophotometric assays, the EMMA method is
rapid, automatable, and requires only nanoliter volumes of potentially expensive reagents.
Fluorimetric activity assays
Assays based on fluorescence are continuous, more sensitive than photometric assays, and
have sensitivity comparable with that of end-point radioisotope assays [32]. High sensitivity
also enables the use of low substrate concentrations and requires small amounts of enzyme.
Many assays take advantage of compatible fluorescent substrates, for example 4-
methylumbelliferyl sulfate (MUS) [32, 33], 2-naphthyl substrate [34], or pyrene 1-sulfate
[35]. Others attach fluorescent moieties to substrates of interest, for example
oligosaccharides [36] or a variety of acids [37].
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A fluorimetry-based activity assay has been described that utilizes the regeneration of PAPS
from PAP by the auxiliary enzyme phenol ST with MUS as the sulfo donor (Scheme 5A)
[32]. The reaction was coupled with the alcohol ST, human dehydroepiandrosterone
(hDHEA–ST), and the 4-methylumbelliferone (MU) product served as a fluorescent
indicator of enzyme turnover to monitor the alcohol ST activity. The Vmax, Km, and Ki
values for MUS and dehydroepiandrosterone (DHEA) were determined from initial rate
kinetics of the 450 nm emission on 360 nm excitation. This suitable excitation wavelength
was determined to prevent interference from the absorbance of MUS. The observed
fluorescence intensity was significantly dependent on the pH value but less dependent on
temperature. The change of fluorescence intensity of 4-methylumbelliferone was sufficiently
sensitive to measure the activity of nanogram or picomole amounts of enzyme, comparable
with a previously reported radiometric assay. This method has the potential for the
development into a high-throughput assay for measuring the AST activity of biological
samples using a microplate reader. The activity of other enzymes, associated with either
sulfonation (STs) or desulfonation (sulfatases) might also be determined by use of this
approach.
A similar coupled real-time fluorimetric enzyme assay was developed for monoamine-
preferring phenol ST (SULT1A3). SULT1A1 was used to regenerate PAPS, again using
MUS as a sulfo group donor (Scheme 5B). MU was continuously monitored as SULT1A3-
catalyzed sulfo group transfer to dopamine with PAPS [33] to determine activity, Vmax, Km,
and Ki values of SULT1A3. These values were consistent with values previously determined
by use of radiometric assay procedures at comparable sensitivity [38].
A fluorescence-based HPLC assay for determination of human estrogen ST (SULT1E1)
inhibition was developed using 1-hydroxypyrene to investigate the inhibitory effect of
endocrine-disrupting compounds (EDC) [35]. SULT1E1 is involved in the regulation of
17β-estradiol responsiveness and is believed to protect peripheral tissues from excessive
estrogenic effects. 1-Hydroxypyrene was selected as the substrate because of its fluorescent
properties, the fluorescent properties of its metabolite, pyrene 1-sulfate, and because it is
noncarcinogenic unlike the metabolites of benzo [a]pyrene, which had been used in previous
studies. A gradient HPLC separation of 1-hydroxypyrene and pyrene 1-sulfate on a
reversed-phase C18 column was developed and optimized The formation of pyrene 1-sulfate
was quantified fluorescently, with detection limits of 0.1 pmol for pyrene 1-sulfate and 1-
hydroxypyrene. The double reciprocal plot of the kinetic data afforded Km and Vmax values
for 1-hydroxypyrene similar to those previously reported. A library of 19 compounds with
known estrogenic properties was tested at a single concentration, and IC50 values were
determined for the ten strongest SULT1E1-inhibiting compounds. Negative controls
representing 100 % inhibition and positive controls representing 0 % inhibition were used to
demonstrate assay reliability. The method was highly reproducible for SULT1E1 activity
screening and inhibition studies. This assay offers opportunities to investigate human tissue
samples in the presence of EDCs, and can be used to establish causative predictions between
levels of EDCs and health problems associated with SULT1E1.
In summary, although fluorescence-based assays are convenient and extremely sensitive,
they can be difficult to design and develop, particularly when the substrates and/or products
are not fluorescent.
Mass spectrometric activity assays
Unfortunately, many ST substrates and reaction products do not contain a chromophore or
fluorophore necessary to perform spectrophotometric and/or spectrofluorimetric assays, and
in some cases radioisotope use is undesirable. Assays based on mass spectroscopy are useful
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in these cases. Modern soft-ionization methods enable sensitive analysis of sulfated
compounds without fragmentation of the fragile O-sulfo and N-sulfo linkages and can
provide unambiguous differentiation of substrate from product. Most of the reported mass
spectrometric assays have utilized electrospray ionization–mass spectrometry (ESI–MS)
[39–42], some have combined MS analysis with liquid chromatography (LC–MS) [43] and
one has used the hydrogen–deuterium exchange upon epimerization procedure with liquid
chromatography–mass spectrometry (DEEP–LC–MS) [44].
An activity assay based on ESI–MS using an ion-trap mass spectrometer was developed and
applied to a bacterial carbohydrate ST, NodST, in which the enzyme catalyzes the transfer
of a sulfo group from PAPS to chitobiose, yielding PAP and 6-O-sulfochitobiose [39]. The
total analysis time was reportedly comparable with that of a standard spectrophotometric
assay. The activity and Km for PAPS and chitobiose, the Vmax and Ki for PAP, and the
mode of inhibition were all determined. The Km value for PAPS was consistent with
literature values obtained by TLC assay, validating the ESI–MS assay as a reliable and
accurate method for determining the kinetic data for NodST. Unlike the earlier radiometric
method using TLC, ESI–MS was also capable of obtaining the Km value for chitobiose. The
substrates and products of many ST-catalyzed reactions, including those catalyzed by
NodST, do not have the chromophores needed for spectrophotometric methods. Strategies
relying on the synthesis of artificial chromogenic or fluorogenic substrates are time-
consuming to develop and are not always feasible. In contrast, ESI–MS-based assays can
usually be used to assay any ST as long as an internal standard with a structure and
ionization efficiency similar to those of either product or substrate is available. An
additional advantage is that substrate and product concentrations can often be
simultaneously analyzed during the course of the reaction, making the assay an efficient and
accurate method for determining enzyme kinetic data. It is noteworthy that substrate
concentration is in excess at the beginning of the reaction and is depleted at reaction
completion so the accuracy of the measurement of substrate and product is not identical
throughout the reaction. LC–MS will continue to be used to investigate the catalytic
mechanism of NodST and to identify ST inhibitors. In the future it is likely that ESI–MS
based assays will be adapted to study many other mammalian carbohydrate STs of
therapeutic interest.
ESI–MS assays have been applied to microbial STs, for example in the assay of
Mycobacterial carbohydrate ST (Stf0) [40]. This enzyme catalyzes sulfo group transfer from
PAPS to trehalose to form 2-O-sulfotrehalose (Scheme 6). The product was quantified
relative to internal standard by use of single-point normalization factors. Initial rate kinetics
were studied. Analysis of both saturation and double-reciprocal plots using nonlinear fitting
to the Michaelis–Menten equation led to the determination of the catalytic and product
inhibition mechanisms, Km, and turnover number (kcat) values for trehalose and PAPS. The
kinetic constants for trehalose were in excellent agreement with those previously obtained
by use of a TLC assay. The results for PAPS were the first reported values and the Km value
of PAPS is similar to those measured for other STs.
Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometry has also been used
to detect noncovalent complexes. This was also the first study to provide detailed
mechanistic data for Stf0. The power of mass spectrometry is that in addition to providing
an assay of enzymatic activity, it also can provide an understanding of the structure,
mechanism, and function of biologically important STs.
An LC–ESI–MS-based assay of tyrosylprotein ST-1 and ST-2 that relies on peptides as
substrates was developed to determine kinetic data for the purified individual isozymes [43].
A 1:1 mixture of both isozymes was used to address the possibility that the two isozymes
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work in synergy within the Golgi. This HPLC–ESI–MS assay, unlike previous radioisotopic
analysis, was able to differentiate between the formation of monosulfated and disulfated
products by using RP-LC coupled directly to a linear ion-trap mass spectrometer equipped
with an ESI source. The optimum concentrations of TPST-2, TPST-1, and the 1:1 TPST-1–
TPST-2 mixture in the assay reactions were determined to be in the micromolar range.
Initial velocity kinetics of each reaction were fitted to the Michaelis–Menten equation to
obtain Km, Vmax, and kcat for PAPS and other substrates. The accuracy and precision of the
method for quantification were internally validated by running replicates of monosulfated
and disulfated standards and the average matrix spike recoveries were 103±7 % and 101±12
% for the monosulfated and disulfated products, respectively. This assay uniquely
determines differences in the kinetic constants of sulfation reactions in peptides with
multiple tyrosine sulfation sites, providing critical information on enzyme specificity. It can
also be used to test potential inhibitors of these isozymes, and to help determine the catalytic
mechanism of TPST-1 and TPST-2. Development of this method has proved to be an
essential step in investigating the kinetic data of sequential tyrosine sulfation of chemokine
receptors by TPSTs and in determining their catalytic mechanism. LC–ESI–MS analysis
should also be applicable to the study of other chemokine receptor substrates, to test
potential inhibitors, and to determine the mechanisms of tyrosylprotein ST isozymes.
Because radiolabeled materials are not required in the ESI–MS assay, and because the
analysis time can be comparable with that of standard UV techniques, mass spectrometry-
based assays are expected to become competitive with, and in some cases more convenient
than, traditional methods. Mass spectrometric assays have a distinct advantage over
radiometric assays because they can differentiate between mono, di, and polysulfonation,
common in many natural products, providing critical information on ST specificity.
Conclusions and perspectives
This review has focused on comparing recent advances in radiometric, photometric,
fluorimetric, and mass spectrometric ST assay methods (Table 1). Other promising but less
popular techniques for measuring ST activity include chemoluminescence [45] and HPLC
[46].
Radiolabeling is still the recommended method for assaying ST enzyme activity. Although
these assays are extremely sensitive, their hazard levels, accuracy, and non-continuous
nature keep them from being an ideal method. Because of the ease of application,
radiometric methods are often not optimized and only adopted for quick use. Radiolabeled
assays will certainly continue to be used, but will require improvement and proper
adjustment for each enzyme system.
Photometric and fluorimetric assays are generally less hazardous, less costly, high-
throughput, and enable accurate and continuous analysis. Unfortunately, these assays cannot
always be applied, as many substrates and/or products of interest do not contain
chromophores or fluorophores. The preparation of chromogenic or fluorogenic substrates
remains a challenge of design and synthesis for the chemist.
Mass spectrometric assays are an excellent option for substrates and/or products which are
neither chromogenic nor fluorogenic. These assays are highly accurate with low hazards, but
they require costly equipment and are discontinuous. Because mass spectrometry is
increasingly becoming accessible in operation and maintenance, its use to assay enzymes
and to screen inhibitors in pharmaceutical research is gradually increasing [47]. These
assays are especially interesting for carbohydrate ST application because they enable
measurement of kinetic constants for polymeric substrates with multiple reactive sites.
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Moreover these carbohydrate STs are attracting increasing interest for applications in
inflammation and cancer and as novel therapeutic targets [48].
Each assay method described in this review has benefits and limitations that should be taken
into account when selecting the optimum method for a particular ST (Table 2). In the future,
less expensive, safer, and more sensitive assays will be required for obtaining better insight
into the activity and substrate-binding properties of STs. Defined substrates, carefully
designed for individual STs, especially those that enable label-free detection, should also
provide more insight. Further method development of ST assays is critical, because
advances in assay development for a single ST can often be applied broadly to many STs for
a variety of reactions and end applications. STs increasingly have a variety of important
applications and improved assays are clearly required to determine their activity and take
full advantage of their potential.
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AST-IV Aryl sulfotransferase type IV
ATP Adenosine triphosphate




ESI–MS Electrospray ionization–mass spectrometry
GlcNAc N-Acetylglucosamine
hDHEA-ST Human dehydroepiandrosterone sulfotransferase
HEC High endothelial cell






NDST-1 N-Deacetylase N-sulfotransferase type 1
NodST Bacterial carbohydrate sulfotransferase
N-ST N-Sulfotransferase
NPAPS 3′-Phosphoadenosine 5′-phosphosulfate
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SDS-PAGE Sodium dodecyl sulfate–polyacrylamide gel electrophoresis
ST Sulfotransferase
STF0 Mycobacterial carbohydrate sulfotransferase
SULT-1A1 Phenyl sulfotransferase type 1A1
SULT-1A3 Phenyl sulfotransferase type 1A3
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PAPS is biosynthesized in the cytosol of an eukaryotic cell and used there by cytosolic STs
to transfer sulfo groups (red) to small endogenous and exogenous compounds, for example
steroids. PAPS is also transported to the Golgi where it is used by membrane STs to transfer
sulfo groups (red) to hydrophilic molecules, for example carbohydrates. STs in the Golgi
consist of a cytosolic tail, transmembrane (TM) domain, and catalytic domain
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ST-catalyzed transfer of sulfo group (red) from PAPS donor to R–XH acceptor (R = sugar or
peptide or small cytosolic molecules. When X = O the ST is an O-STand when X = NH/NR
the ST is an N-ST)
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2-O-ST sulfonates N-sulfoheparosan and CDSNS heparin. The polysaccharide product can
be quantified and then treated with heparin lyase to afford disaccharides for characterization
against disaccharide standards, using HPLC with scintillation detection to establish the
position of the added sulfo group
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HEC-GlcNAc-6-ST and NDST-1 act on N-acetylglucosamine and de-N-sulfonated heparin,
respectively. The 35S-labeled product with O-sulfo and N-sulfo groups can easily be
separated from PAP35S and quantified by scintillation counting
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PAPS regeneration system. AST-IV catalyzes the transfer of the sulfo group from the less
expensive donor, PNPS. The sulfo group is then transferred to the substrate of interest by the
O-ST enzyme. The PNP formed in the coupled reaction absorbs at 400 nm
Paul et al. Page 16














Determination of ST activity by increase in MU fluorescence. A DHEA-ST and B
SULT1A3 activity by regeneration of PAPS with auxiliary SULT1A1 enzyme reducing the
fluorescence of MU
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Transfer of sulfo group from PAPS to trehalose by Stf0
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Table 1
ST enzymes and assay methods
Enzyme Substrate/acceptor Detected product Assay method Km
Human cytosol-localized
Aryl sulfotransferase IV (AST-IV) Aryl alcohol O-Sulfated ester, PAPS* P* 26.4 μmol L−1
N-deacetylase/N-sulfotransferase (NDST-1) -GlcAβ1-4GlcNα1-4- -GlcAβ1-4GlcNSα1-4-, PAPS* R* 1.0 μmol L−1
Phenol sulfotransferase (SULT1A1) Phenol, PAP Sulfated phenol, PAPS*, 4-
methylumbelliferone (MU)
P*, F 0.84 μmol L−1
Dehydroepiandrosterone sulfotransferase
(DHEA-ST: SULT2A1)
DHEA DHEAS, PAPS* F* 4.7 μmol L−1
Monoamine-preferring phenol ST
(SULT-1A3)
Dopamine, catecholamine, phenol Dopamine sulfate, sulfated phenol,
PAPS*
F* 6.8 μmol L−1
Estrogen ST (SULT-1E1) Estrogen, 1-hydroxypyrene Estrogen sulfate, pyrene-1-sulfate*,
PAPS
F* 6.4 nmol L−1
Human Golgi-localized
Chondroitin 4-sulfotransferase (C4ST) GlcAβ1-3GalNAcβ1-4 GlcAβ1-3GalNAc(4S)β1-4 R n.r.
Chondroitin 6-sulfotransferase (C6ST) NeuAcα1-3 Galβ1-4GlcNAc- NeuAcα1-3 Gal (6S)β1-4GlcNAc- R n.r.
NeuAcα1-3 Galβ1-4GlcNAc(6S) NeuAcα1-3 Gal(6S)β1-4GlcNAc(6S) R n.r.
Heparan sulfate 2-sulfotransferase (HS2ST) -IdoAα1-4GlcNSα1-4 -IdoA(2S)-GlcNS_α1-4 R n.r.
Tyrosylprotein sulfotransferase (TPST),
TPST-1, TPST-2
Tyrosine within highly acidic
motif of polypeptide/protein
Tyrosine-sulfated protein R, M* 21 mmol L−1
High endothelial cell-GlcNAc6-O-ST
(HEC-GlcNAc6ST: LSST)








Trehalose Trehalose-2-sulfate M* 15 mmol L−1
R, radiometric assay; P, photometric assay; F, fluorimetric assay, M, mass spectrometric assay; n.r., not reported
*
Km values reported for substrate and assay methods are indicated with an asterisk
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Table 2
Comparison of ST assay methods
Assay Method Benefits Limitations
Radiometric Highly sensitive, fast, specific Hazardous, expensive, discontinuous
Photometric Fast, inexpensive, continuous, high-throughput capable, kinetic
constants easily measurable, requires few sample-processing
steps, accurate
Requires chromogenic substrate, relatively less
sensitive
Fluorimetric Highly sensitive, fast, continuous, inexpensive, high-
throughput capable, kinetic constants easily measurable,
specific, requires few sample-processing steps, accurate
Requires fluorogenic substrate
Mass spectrometric Highly specific, highly sensitive, highly accurate Requires expensive equipment, discontinuous,
requires specialized skills
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